{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T03:21:47Z","timestamp":1649128907559},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,7,15]]},"DOI":"10.2169\/internalmedicine.2532-18","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T18:11:54Z","timestamp":1553710314000},"page":"2073-2077","source":"Crossref","is-referenced-by-count":0,"title":["Primary Chest Wall MYC\/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations"],"prefix":"10.2169","volume":"58","author":[{"given":"Kazuharu","family":"Kamachi","sequence":"first","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kubota","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"},{"name":"Department of Transfusion Medicine, Saga University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Nagaie","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyosuke","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Ogusu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kidoguchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Kusaba","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Kizuka-Sano","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsujiro","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Ando","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Kai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saga University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Kojima","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisaburo","family":"Sueoka","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Saga University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 34: 335-347, 2006."},{"key":"2","unstructured":"2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. IARC Publications, Lyon, 2017."},{"key":"3","unstructured":"3. Aozasa K, Takakuwa T, Nakatsuka S. Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation. Adv Anat Pathol 12: 324-331, 2005."},{"key":"4","unstructured":"4. Johnson NA, Slack GW, Savage KJ, et al. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 30: 3452-3459, 2012."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Am J Surg Pathol 37: 323-332, 2013.","DOI":"10.1097\/PAS.0b013e31826cebad"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Iwasa Y, Okada A, Takenaka H, et al. Primary malignant lymphoma originating from the chest wall without preceding pleural disease. Intern Med 56: 681-686, 2017.","DOI":"10.2169\/internalmedicine.56.7053"},{"key":"7","unstructured":"7. Shao C, Guo Y, Xu X, et al. Non-pyothorax-associated primary pleural lymphoma without pleural effusion in an immunocompetent patient: a case report and literature review. J Thorac Dis 10: e368-e371, 2018."},{"key":"8","unstructured":"8. Hirai S, Hamanaka Y, Mitsui N, Morifuji K, Sutoh M. Primary malignant lymphoma arising in the pleura without preceding long-standing pyothorax. Ann Thorac Cardiovasc Surg 10: 297-300, 2004."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sun ML, Shang B, Gao JH, Jiang SJ. Rare case of primary pleural lymphoma presenting with pleural effusion. Thorac Cancer 7: 145-150, 2016.","DOI":"10.1111\/1759-7714.12256"},{"key":"10","unstructured":"10. Tabatabai A, Hashemi M, Ahmadinejad M, et al. Primary chest wall lymphoma with no history of tuberculous pyothorax: diagnosis and treatment. J Thorac Cardiovasc Surg 136: 1472-1475, 2008."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hsu PK, Hsu HS, Li AF, et al. Non-Hodgkin's lymphoma presenting as a large chest wall mass. Ann Thorac Surg 81: 1214-1218, 2006.","DOI":"10.1016\/j.athoracsur.2005.11.044"},{"key":"12","unstructured":"12. Yang X, Xu X, Song B, Zhou Q, Zheng Y. Misdiagnosis of primary pleural DLBCL as tuberculosis: a case report and literature review. Mol Clin Oncol 8: 729-732, 2018."},{"key":"13","unstructured":"13. Petrich AM, Gandhi M, Jovanovic B, et al. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood 124: 2354-2361, 2014."},{"key":"14","unstructured":"14. Oki Y, Noorani M, Lin P, et al. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol 166: 891-901, 2014."},{"key":"15","unstructured":"15. Howlett C, Snedecor SJ, Landsburg DJ, et al. Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. Br J Haematol 170: 504-514, 2015."},{"key":"16","unstructured":"16. Dunleavy K, Fanale MA, Abramson JS, et al. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. Lancet Haematol 5: e609-e617, 2018."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Landsburg DJ, Falkiewicz MK, Maly J, et al. Outcomes of patients with double-hit lymphoma who achieve first complete remission. J Clin Oncol 35: 2260-2267, 2017.","DOI":"10.1200\/JCO.2017.72.2157"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chen AI, Leonard JT, Okada CY, et al. Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma. Leuk Lymphoma 59: 1884-1889, 2018.","DOI":"10.1080\/10428194.2017.1406085"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Landsburg DJ, Petrich AM, Abramson JS, et al. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. Cancer 122: 559-564, 2016.","DOI":"10.1002\/cncr.29781"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Aukema SM, Kreuz M, Kohler CW, et al. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica 99: 726-735, 2014.","DOI":"10.3324\/haematol.2013.091827"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Turakhia SK, Hill BT, Dufresne SD, Nakashima MO, Cotta CV. Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics. Am J Clin Pathol 142: 339-346, 2014.","DOI":"10.1309\/AJCPBWVHTF7RRSA4"},{"key":"22","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","volume":"126","author":"C Copie-Bergman","year":"2015","unstructured":"22. Copie-Bergman C, Cuilliere-Dartigues P, Baia M, et al. MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study. Blood 126: 2466-2474, 2015.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ye Q, Xu-Monette ZY, Tzankov A, et al. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. Oncotarget 7: 2401-2416, 2016.","DOI":"10.18632\/oncotarget.6262"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nahar R, Ramezani-Rad P, Mossner M, et al. Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood 118: 4174-4178, 2011.","DOI":"10.1182\/blood-2011-01-331181"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Deweindt C, Kerckaert JP, Tilly H, Quief S, Nguyen VC, Bastard C. Cloning of a breakpoint cluster region at band 3q27 involved in human non-Hodgkin's lymphoma. Genes Chromosomes Cancer 8: 149-154, 1993.","DOI":"10.1002\/gcc.2870080303"},{"key":"26","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1182\/blood.V95.8.2719","volume":"95","author":"Y Hosokawa","year":"2000","unstructured":"26. Hosokawa Y, Maeda Y, Ichinohasama R, Miura I, Taniwaki M, Seto M. The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t (3;7) (q27;p12) translocation in a patient with diffuse large B-cell lymphoma. Blood 95: 2719-2721, 2000.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ichinohasama R, Miura I, Funato T, et al. A recurrent nonrandom translocation (3;7) (q27;p12) associated with BCL-6 gene rearrangement in B-cell diffuse large cell lymphoma. Cancer Genet Cytogenet 104: 19-27, 1998.","DOI":"10.1016\/S0165-4608(97)00412-3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Katsura Y, Ohta I, Yoshida C, Ohtani H, Komeno T. Diffuse large B-cell lymphoma carrying both t (3 ; 7) (q27 ; p12) and t (8 ; 14) (q24 ; q32). Intern Med 50: 905-908, 2011.","DOI":"10.2169\/internalmedicine.50.4860"},{"key":"29","unstructured":"29. Cobb BS, Smale ST. Ikaros-family proteins: in search of molecular functions during lymphocyte development. Curr Top Microbiol Immunol 290: 29-47, 2005."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360: 470-480, 2009.","DOI":"10.1056\/NEJMc090454"},{"key":"31","unstructured":"31. Martinelli G, Iacobucci I, Storlazzi CT, et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 27: 5202-5207, 2009."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/14\/58_2532-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T05:43:59Z","timestamp":1574401439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/14\/58_2532-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":31,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2532-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}